Alamar Biosciences Quarterly Income Statement
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
25.27-0.64 (-2.47%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alamar Biosciences revenue and earnings
In the quarter ended Jun 30, 2026, Alamar Biosciences generated $29.4 million in revenue. Alamar Biosciences reported a net loss of $13.2 million. Gross margin was 60.2% and operating margin -46.0%.
Diluted earnings per share came in at -$0.22.
Summary generated from market data by MetaCap's automated system. Methodology
Alamar Biosciences income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Revenue | 29.43M | 26.04M | 16.16M | 13.09M |
| Revenue growth (YoY) | — | — | — | — |
| Cost of Revenue | 11.71M | 11.58M | 7.58M | 6.70M |
| Gross Profit | 17.72M | 14.46M | 8.58M | 6.39M |
| Operating Expenses | 31.25M | 26.80M | 16.50M | 14.94M |
| Research & Development | 13.82M | 13.02M | 8.89M | 8.30M |
| Selling, General & Admin | 17.43M | 13.79M | 7.61M | 6.64M |
| Operating Income | -13.53M | -12.35M | -7.92M | -8.55M |
| Interest Expense | 224.00K | 223.00K | 48.00K | 46.00K |
| Pretax Income | -13.29M | -20.86M | -7.02M | -7.66M |
| Income Tax | -93.00K | 464.00K | — | — |
| Net Income | -13.20M | -21.32M | -7.02M | -7.66M |
| Net Income growth (YoY) | — | — | — | — |
| EPS (Basic) | -0.22 | -1.74 | -0.62 | -0.68 |
| EPS (Diluted) | -0.22 | -1.74 | -0.62 | -0.68 |
| Shares Outstanding (Basic) | 58.67M | 12.26M | 11.41M | 11.26M |
| Shares Outstanding (Diluted) | 58.67M | 12.26M | 11.41M | 11.26M |
| EBITDA | -12.40M | -11.18M | -7.00M | -7.67M |
| Gross Margin | 60.21% | 55.53% | 53.09% | 48.80% |
| Operating Margin | -45.98% | -47.42% | -49.00% | -65.33% |
| Net Margin | -44.85% | -81.91% | -43.45% | -58.51% |
This table shows 4 quarterly periods of Alamar Biosciences's income statement, from Q2 2026 back to Q? 2025, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ALMR's reporting calendar. What is a income statement?